Stella K. Vnook
AeroLeads people directory · profile

Stella K. Vnook Email & Phone Number

Chief Executive Officer | Founder at AVIVA VENTURES
Location: Greater Philadelphia, United States, United States 17 work roles 5 schools
1 work email found @purduepharma.com 1 phone found area 215 LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 1 phone

Work email s****@purduepharma.com
Direct phone (215) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Chief Executive Officer | Founder
Location
Greater Philadelphia, United States, United States

Who is Stella K. Vnook? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Stella K. Vnook is listed as Chief Executive Officer | Founder at AVIVA VENTURES, based in Greater Philadelphia, United States, United States. AeroLeads shows a work email signal at purduepharma.com, phone signal with area code 215, and a matched LinkedIn profile for Stella K. Vnook.

Stella K. Vnook previously worked as Chief Executive Officer | Corporate Board at Likarda and Founder | Board Chair | President at Oral Biolife Inc.. Stella K. Vnook holds Mba, Marketing/Marketing Management, General from La Salle University.

Company email context

Email format at AVIVA VENTURES

This section adds company-level context without repeating Stella K. Vnook's masked contact details.

*@purduepharma.com
68% confidence

AeroLeads found 1 current-domain work email signal for Stella K. Vnook. Compare company email patterns before reaching out.

Profile bio

About Stella K. Vnook

Chief Executive Officer, Founder, Board Member, C-suite Advisor with 25 years’ experience driving transformational change for global clinical development portfolios from early-stage R&D to commercialization. She has an extensive background in building and managing successful start up ventures, commercial scale up, strategy/ execution to support brand launch, research & development acceleration, IP strategy, Corporate Board selection/ formation, business development/ investment strategy and venture capital initiatives, as well as managed markets and healthcare economics.I am passionate about transformation of pharmaceutical industry to an innovative, outcome driven industry. As a scientist and business partner, I work extensively with Business Development and R&D to transform patient care and bring new medicine and health technology to market. Specialties: Drug Development, taking the molecule from pre-IND through Clinical Trials to Commercialization. General Management, Corporate start up and turnaround, business development (M&A & licencing), P&L accountability, Team Development, fund razing (IPO, public, private), setting up operations, Managed Markets Expert, pharmaceutical, biotech, consumer health and wellness.

Listed skills include Pricing, Marketing Strategy, Forecasting, Segmentation, and 29 others.

Current workplace

Stella K. Vnook's current company

Company context helps verify the profile and gives searchers a useful next step.

AVIVA VENTURES
Aviva Ventures
Chief Executive Officer | Founder
Philadelphia, PA, US
AeroLeads page
17 roles · 22 years

Stella K. Vnook work experience

A career timeline built from the work history available for this profile.

Chief Executive Officer | Founder

Aviva Ventures

Philadelphia, PA, US

Chief Executive Officer | Corporate Board

Current

Kansas City, Missouri, US

Responsible for making major corporate decisions, managing overall operations, and setting the company's strategic direction. Oversee employment decisions at the executive level of the company. Lead a team of executives to consider major decisions including acquisitions, mergers, joint ventures, or large-scale expansion.

Apr 2023 - Present

Founder | Board Chair | President

Current
  • An innovative dental technology that combines the benefits of an antimicrobial and regenerative medicine to treat variety of oral and bone-related conditions, starting with initial indication for periodontitis..
  • Platform Technology: The antimicrobial and bone-regenerating technology can be applied to many applications that require a sterile, high-quality seal with bone, including dental and orthopedic implants. The.
Apr 2022 - Present

Co-Founder | Board Of Directors

Current

Kaida Biopharma is at the forefront of revolutionizing the fight against ovarian and women’s cancers with our KAD 101 and KAD 102 leading assets. Based on a groundbreaking research of G129R, it can potentially significantly enhance current treatment efficacy. The innovative approach combines cutting-edge research and technology to address critical unmet.

Jun 2024 - Present

Board Of Directors

Current

Buffalo, New York, US

Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024..

Aug 2024 - Present

Founder | President | Executive Advisor

Current

Transforming Potential into Success: Building, Turning Around, and Restructuring CompaniesWe specialize in optimizing your company’s potential by providing expert guidance for startups, universities, and incubator communities. Our services include developing foundational strategies, designing spin-out approaches, establishing funding pathways, and.

Mar 2015 - Present

Mentor-In-Residence (Mir) / Entrepreneur In Residence (Eir)

Current

University Park, PA, US

Apr 2024 - Present

Corporate Board

Newark, Delaware, US

Development-stage biotech company, focused on cancer, rare diseases, diabetes and cardiovascular conditions.

Apr 2022 - Apr 2024

Founder | Corporate Board | Chief Executive Officer

Naki Therapeutics

NAKI Therapeutics is an innovative research-focused biopharmaceutical company. Our core technology is surrounding Chimeric Antigen Receptor (CAR)-Natural Killer (NK) immunotherapy with ground-breaking allogeneic or ‘off-the-shelf’ expansion technology and a ‘first-in-class’ solid tumor molecular target-CD147.Our approach is to re-engineer NK cells-which.

Oct 2020 - Sep 2022

Founder | Board Chair | President

Pipersville, PA, US

Our Mission is to become an industry leader in Cell Therapy Development along with evolving and innovative treatment options starting with Type 1 Diabetes and evolving to treat sub-set of patients with Type 2. MaiCell seeks to utilize its unique patented xenotransplantation technology of islet-cells, to develop effective treatments for Diabetes Mellitus.

Jan 2020 - Mar 2022

Chief Executive Officer

Doylestown, Pennsylvania, US

Diverse Biotech, Inc. is an innovative, clinical-stage bio-pharmaceutical research company that is committed to discovering and developing novel therapeutics from its proprietary and patented CUSP(tm) technology platform in cancer research. Diverse Biotech is focused on medical discoveries and the development of new molecules for the treatment of Oncology.

Dec 2018 - Nov 2020

Vice President | Managed Markets | Trade | Sales |Head Of Patient & Access Reimbursement Teams

The Vice President of Managed Markets & Trade is responsible for the development, implementation and execution of all managed care strategies across the entire portfolio, supporting upcoming launches and Business Development assessment. The US healthcare landscape is highly complex and with the enactment of the Affordable Care Act Legislation and proposed.

Mar 2014 - Feb 2019

Head Of Global Marketing & Strategy, Softgel Technology

Somerset, NJ, US

This position reached beyond the traditional VP of marketing and strategy role. This position allowed me to combine my passion for marketing, strategy and sales with my experience of building effective teams and expand it globally. Starting with launching NEW RP Scherer Softgel brand —the leading delivery technology provider in target customers and.

Jan 2012 - Mar 2014

Strategy Development Director

Rahway, New Jersey, US

Responsible for characterizing future opportunities for the Company by leading cross-functional teams to develop key capabilities allowing the U.S. Commercial team to optimize our business 3-5 years in the future.

Jun 1998 - Jan 2012

Sales & Marketing Director (Transformational Change And Innovation)

Rahway, New Jersey, US

Lead the strategy and execution of new division within Merck Marketing & Sales group to meet Customer Needs. Launch a new sales division focusing on customer needs (included large HMO/ PBM, Hospital and top tier Medical Groups). Drive Managed Care pull-though, sales/ managed care formulary decisions and increase Trust and Value proposition for Merck. Lead.

Nov 2007 - Oct 2010

Managed Markets: National Accounts Executive, Marketing & Profitability Models

Rahway, New Jersey, US

As a Sales Executive, lead Managed Care Account negotiations, financial analysis and customer relationship. As a Marketing Executive, developed and executed segment strategy for HMO/ PRM and National Medicaid. Proven results in strategy, planning, and execution of preferred formulary status and pull-through resources to drive revenue within a sales line.

2004 - 2008 ~4 yrs

Medical & Pharmacy Affairs | Marketing

Rahway, New Jersey, US

Lead marketing & strategy for pharmacy/ wholesalers division. Managed pharmacy academic and professional relationship with national and local pharmacy organizations and schools of pharmacy. Established and lead a PharmD preceptor program for Merck Pharmacy & Academic Affairs. Lead continuing education programs and educational events for Merck.

May 1999 - Mar 2004
5 education records

Stella K. Vnook education

Mba, Marketing/Marketing Management, General

La Salle University

Doctoral Degree (Such As Doctorate Of Philosophy), Healthcare: Public / Global Health Economics

Oklahoma State University

Pharmacy (Oncology Focus) - Current License In Pa

Temple University School Of Pharmacy

Bachelor Of Arts - Ba, Biology/ Anthropology/ Mathematics

Temple University

Education record

Northeast High School
FAQ

Frequently asked questions about Stella K. Vnook

Quick answers generated from the profile data available on this page.

What company does Stella K. Vnook work for?

Stella K. Vnook works for AVIVA VENTURES.

What is Stella K. Vnook's role at AVIVA VENTURES?

Stella K. Vnook is listed as Chief Executive Officer | Founder at AVIVA VENTURES.

What is Stella K. Vnook's email address?

AeroLeads has found 1 work email signal at @purduepharma.com for Stella K. Vnook at AVIVA VENTURES.

What is Stella K. Vnook's phone number?

AeroLeads has found 1 phone signal(s) with area code 215 for Stella K. Vnook at AVIVA VENTURES.

Where is Stella K. Vnook based?

Stella K. Vnook is based in Greater Philadelphia, United States, United States while working with AVIVA VENTURES.

What companies has Stella K. Vnook worked for?

Stella K. Vnook has worked for Aviva Ventures, Likarda, Oral Biolife Inc., Kaida Biopharma, and Firefly Neuroscience.

How can I contact Stella K. Vnook?

You can use AeroLeads to view verified contact signals for Stella K. Vnook at AVIVA VENTURES, including work email, phone, and LinkedIn data when available.

What schools did Stella K. Vnook attend?

Stella K. Vnook holds Mba, Marketing/Marketing Management, General from La Salle University.

What skills is Stella K. Vnook known for?

Stella K. Vnook is listed with skills including Pricing, Marketing Strategy, Forecasting, Segmentation, Pharmaceutical Sales, Strategy, Product Launch, and Product Development.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.